Laboratory Assessment of Emicizumab Levels in Hemophilia A: Influence of Assay Selection on Reported Results
Background Emicizumab has emerged as a promising therapy for hemophilia A (HA), employing a bypassing mechanism to restore hemostasis. However, since the traditional factor assays cannot be used for measuring the effect of emicizumab, treatment monitoring is difficult. Objectives To assess the impac...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publishing
2025-09-01
|
| Collection: | Clinical and Applied Thrombosis/Hemostasis |
| Accès en ligne: | https://doi.org/10.1177/10760296251378458 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|